International Clinical Trial: Exploration of peripheral blood immune cell heterogeneity and efficacy of Qianlie Xiaozhuo Formula in the treatment of type III chronic prostatitis patients based on single-cell RNA sequencing

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117132) titled 'Exploration of peripheral blood immune cell heterogeneity and efficacy of Qianlie Xiaozhuo Formula in the treatment of type III chronic prostatitis patients based on single-cell RNA sequencing' on Jan. 20.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shunyi Hospital of Traditional Chinese Medicine

Condition: Type III chronic prostatitis

Intervention: Treatment group:Qianlie Xiaozhuo Formula, composition: Anemarrhena 10g, Phellodendron 12g, Chuanxiong 12g, Angelica Dahurica 10g, Raw Astragalus 20g, Corydalis 10g, Cyperus 10g, Dryopteris 15g, Dioscorea 15g, Achyranthes 10g, Motherw...